Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA

Kenan Zhang; Xing Liu; Guanzhang Li; Xin Chang; Shouwei Li; Jing Chen; Zheng Zhao; Jiguang Wang; Tao Jiang; Ruichao Chai

doi:10.20892/j.issn.2095-3941.2023.0227

In the published version of Figure 2¹, an error appeared in Figure 2C on page 1468. In Figure 2C, the Kaplan-Meier estimation of the overall survival of patients with recurrent DG classified according to molecular subtypes was mistakenly covered by the curves of patients with primary DGs during the figure layout process, while the number statistic under the figure is correct. Figure 2C has been updated to correct this mistake. The error does not affect the conclusions of this article. We apologize for the error and for any confusion that it might have caused.

Figure 2C

Kaplan-Meier estimation of the overall survival of patients with recurrent DG classified according to molecular subtypes.

Received June 27, 2023.
Accepted June 29, 2023.

https://creativecommons.org/licenses/by/4.0/

This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Reference

1.↵
2. Zhang K,
3. Liu X,
4. Li G,
5. Chang X,
6. Li S,
7. Chen J, et al.
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA. Cancer Biol Med. 2022; 19: 1460–76.
OpenUrl Abstract/FREE Full Text